Other

Dataset Information

0

Spatial Transcriptomics of IPMN Reveals Divergent Indolent and Malignant Progenitor Phenotypes


ABSTRACT: Purpose: Intraductal papillary mucinous neoplasms (IPMN) occur in 5-10% of the population, but only a small minority progress to pancreatic ductal adenocarcinoma (PDAC). The lack of accurate predictors of high-risk disease leads both to unnecessary operations for indolent neoplasms as well as missed diagnoses of PDAC. Digital spatial RNA profiling (DSP-RNA) provides an opportunity to define and associate transcriptomic states with cancer risk. Results: Our analysis uncovered three distinct epithelial transcriptomic states - "normal-like" (cNL), "low-risk" (cLR), and "high-risk" (cHR) - which were significantly associated with pathologic grade. Furthermore, the three states were significantly correlated with the exocrine, classical, and basal-like molecular subtypes described in PDAC. Specifically, exocrine function diminished in cHR, classical activation distinguished neoplasia (cLR and cHR) from cNL, and basal-like genes were specifically upregulated in cHR. Intriguingly, markers of cHR were detected in NL and LGD regions from specimens with PDAC but not low-grade IPMN. Conclusions: DSP-RNA of IPMN revealed low-risk (indolent) and high-risk (malignant) expression programs that correlated with the activity of exocrine and basal-like PDAC signatures, respectively, and distinguished pathologically low-grade from malignant specimens. These findings contextualize IPMN pathogenesis and have the potential to improve risk stratification.

ORGANISM(S): blank sample Homo sapiens

PROVIDER: GSE278670 | GEO | 2025/01/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-01-29 | GSE63102 | GEO
2015-01-29 | E-GEOD-63102 | biostudies-arrayexpress
2015-01-29 | E-GEOD-63104 | biostudies-arrayexpress
2011-12-01 | E-GEOD-26647 | biostudies-arrayexpress
2011-12-01 | GSE26647 | GEO
2011-05-18 | E-GEOD-29352 | biostudies-arrayexpress
2011-05-18 | GSE29352 | GEO
2018-03-31 | GSE96926 | GEO
2024-04-23 | PXD043111 | Pride
2018-05-01 | PXD008302 | Pride